SSRIs and Hydroxyzine for Avoidant Restrictive Food Intake Disorder
Mar 4, 2024
auto_awesome
Exploring the complexities of Avoidant Restrictive Food Intake Disorder (ARFID) and its treatment modalities, including SSRIs and hydroxyzine. Discussion on diagnosing ARFID, distinguishing it from other eating disorders, and the importance of comprehensive treatment approaches. Insights from a study on using SSRIs and hydroxyzine in children and adolescents for treating ARFID, with positive outcomes observed. Emphasis on dosage recommendations, side effects, and monitoring anxiety levels in severe cases of ARFID management.
Avoidant restrictive food intake disorder is an eating disorder characterized by limited food intake due to sensory sensitivity, fear of adverse consequences from eating, or disinterest in eating. Unlike anorexia or bulimia, it may not involve concerns about body weight or shape. Diagnosis of ARFID can be challenging, especially differentiating it from anorexia. Screening tools and careful exploration of meal habits and preferences are essential to identify ARFID early and tailor treatment.
Comprehensive treatment for individuals with ARFID
Individuals diagnosed with ARFID often require a comprehensive treatment approach, including dietary guidance, feeding therapy, and potentially medication. ARFID can significantly impact social and occupational functioning, emphasizing the importance of effective treatment to improve quality of life. Medications like olanzapine or mirtazapine may be considered, despite limited research supporting their efficacy for ARFID, alongside SSRIs or hydroxyzine.
Medication efficacy and considerations for ARFID
Research suggests that SSRIs may reduce anxiety and improve symptoms in ARFID patients. Combining SSRIs with hydroxyzine may be beneficial, with both medications showing positive effects on weight gain and anxiety levels. Monitoring for potential side effects like drowsiness or headaches is important. Collaborating with professionals for a comprehensive treatment plan and ongoing research is crucial in effectively managing ARFID.
Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode